Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

SELL
$0.01 - $0.1 $5 - $50
-500 Reduced 85.18%
87 $0
Q4 2022

Feb 07, 2023

BUY
$0.08 - $0.23 $6 - $20
87 Added 17.4%
587 $3,000
Q2 2022

Sep 06, 2022

BUY
$0.21 - $0.38 $105 - $190
500 New
500 $2,000
Q2 2022

Aug 12, 2022

SELL
$0.21 - $0.38 $105 - $190
-500 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$0.31 - $2.27 $155 - $1,135
500 New
500 $0

Others Institutions Holding STAB

About Statera Biopharma, Inc.


  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.